Share Name Share Symbol Market Type Share ISIN Share Description
Inflexion Plc LSE:IFX London Ordinary Share GB0003777264 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 7.28p 0.00p 0.00p - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Nonequity Investment Instruments - - - - 0.00

Inflexion (IFX) Latest News

Real-Time news about Inflexion (London Stock Exchange): 0 recent articles
More Inflexion News
Inflexion Takeover Rumours

Inflexion (IFX) Share Charts

1 Year Inflexion Chart

1 Year Inflexion Chart

1 Month Inflexion Chart

1 Month Inflexion Chart

Intraday Inflexion Chart

Intraday Inflexion Chart

Inflexion (IFX) Discussions and Chat

Inflexion (IFX) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Inflexion trades in real-time

Inflexion (IFX) Top Chat Posts

DateSubject
01/10/2016
09:20
Inflexion Daily Update: Inflexion Plc is listed in the Nonequity Investment Instruments sector of the London Stock Exchange with ticker IFX. The last closing price for Inflexion was 7.28p.
Inflexion Plc has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 0 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Inflexion Plc is £0.
06/9/2003
09:00
double6: Inflexion. Shares Magazine rates it as a SPECULATIVE BUY. Current Market Cap = under £10million. Cash at Bank = £11 million. + Investments equivalent to at least 7p per share. At the moment the share is trading at a 40% DISCOUNT TO ASSETS. Any positive news on it's investments should see the share price rising..........
23/8/2003
14:04
britishbear: Results out - all well and good but adminstrative expenses still 2 million a year. How do they expect to cover this expect by using up more and more cash each year. Remains a buy when cash is greater than the current share price with is still at a heavy discount to cash. PDT would be a better bet however.
14/2/2003
15:41
britishbear: Talking to myself but have it on good authority that the BRAINSTORM website will be overhauled on Monday next week. They are also expecting a lot of interest in their MMS provision at the Cannes Conference (as all mobile related stocks are I imagine). Remember BRAINSTORM is 100% owned by Inflexion and will obviously be floated off when market conditions are suitable. Given that IFX trades at a significant discount to cash in the bank and NAV (and losses should be covered by fees this year) IFX remains a buy. Any more deals like the one with Vodafone will certainly help - a classic case of being able to get into a share early. Note the date and the current share price go to http://www.inflexion.com and DYOR. Heard it here first.
14/2/2003
09:49
britishbear: IMPORTANT NEWS http://www.pmn.co.uk/20030213brainstorm.shtml Vodafone UK chooses Brainstorm for MMS This is potentially BIG news for inflexion - must see a share price jump act QUICKLY
15/12/2002
14:16
maywillow: Panagos, Thanks for your post. Is that your predication?, if so, in what time frame will it attain this substantial rise?. Or are you querying that it was once 400p?! And you would be right to query the 400p,but perhaps one day in the far distance future it will attain such an exalted share price level. Cheers
13/2/2002
10:45
enq: Just a thought but yesterday’s purchase may have been made in expectation of progress on the strategy announced in the last interim report to cancel the £34m share premium account in order to pave the way for cancelling repurchased shares. The market may not wish to close the gap between NAV & Mkt Cap but will inevitably respond to large scale purchases & the subsequent reduction in shares in issue. IFX certainly have the cash to achieve this strategy & any repurchasing program should result in significant upward momentum as there are few sellers at current levels. Would also assume that an increasing share price will enhance marketability and thus add further momentum. Any news/views appreciated, particularly on time scale for this strategy. Regards. Enq.
19/12/2001
07:49
zen_: Inflexion PLC - Interim Results RNS Number:9106O Inflexion PLC 19 December 2001 19 December 2001 INFLEXION PLC INTERIM RESULTS for the six months ended 30 September 2001 Inflexion is a mid-market private equity investment company. Quoted on AIM, Inflexion invests its funds in unquoted companies that offer the potential for substantial capital gains. * ANT and Celoxica secure follow-on funding of #2.5 million and $30 million respectively * Inflexion Managers Limited actively pursuing private equity fund management strategy * Cash reserves of #14.7 million * Stated asset value currently 42.7p per share, of which cash represents 22.5p per share * Charles Thompson, with 15 years private equity experience, joined Inflexion Managers as Investment Director from Granville Baird * High profile additions to Inflexion Advisory Panel Inflexion chairman, Michael Freeman, commented: "The Board continues to focus on a strategy of raising and managing UK and European mid-market private equity vehicles in which Inflexion will itself be one of the cornerstone investors. Current market conditions are leading to an increasing flow of sensibly priced and interesting investment opportunities". For further information, please contact: Inflexion 020 7487 9888 Simon Turner/John Hartz Citigate Dewe Rogerson 020 7638 9571 Simon Rigby Rupert Steveney Further information can be obtained from the Company's website, www.inflexion.com Joint CEO's statement Strategy The directors have been active in developing the strategy of the Group over the past six months. As noted in our first year results announcement in July 2001, a key operational milestone for the Group was achieved in June, when Inflexion Managers Limited, a wholly owned subsidiary of Inflexion plc, was authorised to manage collective investment schemes by IMRO. The Group is seeking to leverage the collective investment skills of the Inflexion team by securing future revenue streams through the management of specialist private equity investment vehicles. In October, Inflexion Managers Limited finalised the Preliminary Placement Memorandum ("PPM") for Inflexion Private Equity Fund 2. This fund, designed for institutional private equity investors, is targeted at the UK and European mid-market. Due to the difficult market conditions facing the private equity industry the time taken to raise funds is lengthening. It is anticipated that the Fund will seek a closing during 2002. Financial summary Inflexion's cash position remains healthy with a further #14.7 million available for further investments and to cover our ongoing operational costs. It is the intention of the directors to commit a considerable proportion of these funds to the future investment vehicles managed by Inflexion Managers Limited. The Company net asset value at 30 September 2001 was #27.9 million after an operating loss of #1.2 million, and portfolio write-downs of #3.3 million. In response to the Company's share price, we have recently embarked on the process of obtaining Court consent for a cancellation of the Company's share premium account, creating a distributable reserve, which can be used to cancel repurchased shares in the future. A circular dated 19 December 2001 which details the proposals recommended by the directors, has been distributed to shareholders, and an EGM is scheduled for 14 January 2002. Any purchase and cancellation will, of itself, result in an increase in the net asset value per share for the Company's remaining shareholders. Investment review The current market conditions have made it increasingly difficult for businesses to raise further funds. We were therefore very pleased that both ANT and Celoxica successfully completed funding rounds in the past six months. ANT Limited secured a new #2.5 million round of funding from funds managed by VCF Partners, who invested #2 million in July 2001 at a valuation 1.6 times higher than that upon which Inflexion had invested in September 2000. As part of this funding round, Inflexion invested a further #0.3 million. This uplift in valuation has not been accounted for in this announcement. In October 2001, Celoxica secured its fourth round investment, with $30 million being secured from Advent Venture Partners, Cazenove Private Equity, Intel Capital, the Isis College Fund, Questor VCT and Wind River Ventures. Whilst this represents an encouraging validation of the technology, as well as ensuring that the Company continues to develop the commercial potential of the product, the new funds negotiated a very low entry price, significantly below that at which Inflexion had invested. A provision has been made for the effect of this latest valuation event. During the past six months Inflexion sold its remaining stake in ARC International plc at an IRR of 8%. The decision to exit at a modest profit at the end of the six month lock-up period post IPO has been justified by the continuing fall in the share price after we realised our investment. Our remaining investments, Brainstorm, Connextra and EEP have made reasonable progress in difficult markets. Both Brainstorm and Connextra have undertaken operational restructuring to ensure that there is no imminent need for additional funding. Operational review In May of this year, Charles Thompson joined Inflexion as an Investment Director. Charles has combined extensive experience in private equity with commercial discipline applied in an industrial career. Charles worked in industry for seven years prior to joining Granville Private Equity Managers in 1986 where he made investments across the full range of private equity transactions, including the purchase of 11% of Matalan plc for #2 million, a business now capitalised at around #2 billion. To ensure that Inflexion is at the forefront of sector developments within industries identified as being of immediate interest, the Advisory Panel has recently been augmented with a number of high-profile appointments. Roger Laughton, ex-Chief Executive of Meridian Broadcasting and ex-Chief Executive of Broadcasting and Entertainment at United News and Media, provides valuable insight into the media industry. Andrew Burns, Finance Director of Luminar Leisure plc, the largest operator of late night venues in the UK has been identified for his broad leisure expertise. Virginia Pascoe has more than ten years' experience as a pharmaceuticals industry analyst, and gives Inflexion a capability within the healthcare and pharmaceutical sectors. Finally, Geoff Westmore, previously a partner at PricewaterhouseCoopers latterly as Global Leader of Transaction Services and Strategic M&A augments the private equity and transactional expertise of the team. The advisory panel provides a valuable perspective on trends and issues as well as privileged access to deal opportunities. Outlook The Company has developed strongly both operationally and strategically over the period. The increasingly attractive investment opportunities we are beginning to see, coupled with direct revenue streams from our fund management strategy, should position Inflexion strongly for 2002. Unaudited consolidated profit and loss account for the six month period from 1 April 2001 to 30 September 2001 Audited Unaudited Unaudited 31-Mar 30-Sep 30-Sep 2001 2001 2000 #'000 Note #'000 #'000 - Turnover - - - Cost of sales - - - Gross profit - - (1,803) Administrative expenses (1,255) (838) 72 Other operating income 15 26 (1,731) Operating loss (1,240) ( 812) 289 Profit on disposal of fixed asset 25 - investments 963 Interest receivable and similar income 344 506 (2,499) Amounts written off investments (3,287) - (4) Interest payable and similar charges - - (2,982) Loss on ordinary activities before taxation (4,158) (306) - Tax on loss on ordinary activities - - ( 2,982) Loss for the financial period (4,158) ( 306) - Dividends - - (2,982) Retained loss for the financial period (4,158) (306) Loss per ordinary share (5.87)p - basic and fully diluted 4 (6.36)p (0.47)p Consolidated balance sheet as at 30 September 2001 (unaudited) Audited Unaudited Unaudited 31-Mar 30-Sep 30-Sep 2001 2001 2000 #'000 Note #'000 #'000 Fixed assets 264 Tangible assets 240 308 3 Investments - interests in own shares 3 - 16,707 Investments 3 13,207 19,378 16,974 13,450 19,686 Current assets 255 Debtors 198 260 15,185 Cash at bank and in hand 14,703 15,267 15,440 14,901 15,527 (356) Creditors: amounts falling due within one (451) ( 479) year 15,084 Net current assets 14,450 15,048 32,058 Total assets less current liabilities 27,900 34,734 32,058 Net assets 27,900 34,734 Capital and reserves 654 Called up share capital 654 654 34,386 Share premium account 34,386 34,386 (2,982) Profit and loss account - deficit (7,140) (306) 32,058 Total equity shareholders' funds 27,900 34,734 Unaudited consolidated cash flow statement for the six month period from 1 April 2001 to 30 September 2001 31-Mar 30-Sep 30-Sep 2001 2001 2000 #'000 Note #'000 #'000 (1,597) Net cash flow from operating activities a (1,054) (586) Returns on investment and servicing of finance 963 Interest received 344 508 (4) Interest paid - (2) 959 Net cash inflow from returns on investment and 344 506 servicing of finance - Taxation - - Capital expenditure and financial investment (333) Purchase of tangible fixed assets ( 9) (315) 36 Sale of tangible fixed assets - - (18,625) Purchase of fixed asset investments (392) (18,628) 455 Sale of fixed asset investments 629 - (18,467) Net cash outflow for capital expenditure and 228 (18,943) financial investment - Equity dividends paid - - (19,105) Net cash flow before financing and management (482) (19,023) of liquid resources Management of liquid resources (444) Increase in short term deposits with banks - - Financing 36,020 Issue of ordinary share capital - 36,020 (1,730) Expenses of share issue - (1,730) 34,290 Net cash inflow from financing - 34,290 14,741 (Decrease)/Increase in net cash b ( 482) 15,267 Notes to the unaudited consolidated cash flow statement for the six month period from 1 April 2001 to 30 September 2001 a. Reconciliation of operating loss to net cash flow from operating activities #'000 Continuing Operations #'000 #'000 (1,731) Operating loss (1,240) (812) 33 Depreciation 34 6 (255) (Increase)/decrease in debtors 57 (260) 356 Increase in creditors 95 479 (1,597) Net cash outflow from continuing operations (1,054) ( 586) b. Reconciliation of net cash flow to movement in net funds #'000 #'000 #'000 - Net cash brought forward 15,185 - 15,185 Movement in funds (482) 15,267 15,185 Net funds carried forward 14,703 15,267 NOTES TO THE INTERIM REPORT 1. Basis of preparation The interim financial information, which has been neither audited or reviewed by the Company's auditors, has been prepared on the basis of the accounting policies set out in the Group's statutory accounts for the financial period ending 31 March 2001. The preceding unaudited financial information does not constitute statutory accounts as defined in Section 240 of the United Kingdom Companies Act 1985. The comparative financial information for the financial period ending 31 March 2001 is based on the statutory accounts dated 6 July 2001. These accounts, upon which the auditors have issued an unqualified opinion, have been delivered to the Registrar of Companies. The Group owns certain investments that the Companies Act 1985 requires to be treated as associated undertakings and therefore accounted for using the equity method of accounting. The directors believe that equity accounting for such investments that fall within the definition of associated undertakings would not give a true and fair view of the value generated from the investment activities of the Company, since that is better measured by the inclusion of profits or losses on disposal of such investments in the profit and loss account. Accordingly all investments have been recorded at cost irrespective of whether they fall within the definition of an associated undertaking. This treatment which requires a true and fair override of the Companies Act 1985 is permitted by paragraph 49 of FRS 9 - Associates and Joint Ventures. 2. Statement of total recognised gains and losses A statement of total recognised gains and losses is not provided as there were no gains and losses recognised in the period ended 30 September 2001 other than the profits as set out above. 3. Investments Investment Equity stake ANT Limited 24.5% Celoxica Limited 1.0% Connextra Limited 7.7% European Equity Partners Limited Partnership n/a Micronics Telesystems Limited (trading as Brainstorm) 31% 4. Loss per share The loss per share is based on the loss after tax for the period of #4,158,000 and a weighted average number of shares in issue of 65,370,000. 5. The interim results were approved by the Board on 19 December 2001. END IR GUGRGPUPGGMR Dec-19-2001 07:00 GMT Symbols: GB;IFX Source RNS Regulatory News Service
23/11/2001
23:53
njp: Article is old. Dated 11th October, but buy was presumably bought with November trading update in mind. Article as follows: * Property and Internet speculator Paul Curtis has taken a 2 million share stake (3.1%) in private equity firm Inflexion (IFX). Inflexion, which invests in private firms exposed to large high growth markets, claimed to have 42p of net assets per share at the end of March. What is more it said 23p worth of this was cash which compares favourably to the current share price of 15.25p. However, who knows what the company has been doing since March? Curtis maybe? Interims should be out sometime in November to enlighten us all.
23/11/2001
23:50
maxk: NJP, Sorry, missed it and then found it! And here it is: __________________________________________ * Property and Internet speculator Paul Curtis has taken a 2 million share stake (3.1%) in private equity firm Inflexion (IFX). Inflexion, which invests in private firms exposed to large high growth markets, claimed to have 42p of net assets per share at the end of March. What is more it said 23p worth of this was cash which compares favourably to the current share price of 15.25p. However, who knows what the company has been doing since March? Curtis maybe? Interims should be out sometime in November to enlighten us all. _________________________________________________ Lets hope they do! But it sounds encouraging.
05/11/2001
11:26
zen_: IFX share price seems to have moved by 0.75p. all in our opinion only.
Inflexion share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20161001 10:26:56